WHO, UNAIDS and UNICEF modify recommendations for cotrimoxazole prophylaxis in children: Previous page | 1,2,3,4,5,6,7,8,9,10,11

What follow-up is required?

Statement on use of cotrimoxazole prophylaxis Who should get cotrimoxazole: How long should cotrimoxazole be given: Under what circumstances should cotrimoxazole be discontinued: What doses of cotrimoxazole should be used? What follow-up is required? Other operational issues Patient information Policy and programme information Monitoring and evaluation References

• Assessment of tolerance and adherence: Cotrimoxazole prophylaxis should be a routine part of care of HIV infected children, and be assessed at all regular clinic visits or follow-up visits by health workers and/or other members of multidisciplinary care teams.
• Initial clinic follow-up in children is suggested monthly, and then every three months, if cotrimoxazole is well tolerated.

WHO, UNAIDS and UNICEF modify recommendations for cotrimoxazole prophylaxis in children: 1,2,3,4,5,6,7,8,9,10,11 | Next page